CYPRESS CAPITAL MANAGEMENT LLC (WY) Cara Therapeutics, Inc. Transaction History

CYPRESS CAPITAL MANAGEMENT LLC (WY) portfolio value:

$70,000
portfolio value

CYPRESS CAPITAL MANAGEMENT LLC (WY) quarter portfolio value change:

+2.52%
quarter

Cara Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -53.58% -8.59K shares -76K $9.36 7.44K
Q2 2022 share 0.00% 0 shares -49K $9.13 16.04K
Q1 2022 share Decrease -3.62% -603 shares -8K $12.15 16.04K
Q4 2021 share Increase 0.00% 16.64K shares 203K $12.34 16.64K
Q3 2021 share Decrease -100.00% -16.74K shares -239K $15.45 0
Q2 2021 share Decrease -76.85% -55.57K shares -1.33M $14.27 16.74K
Q1 2021 share Decrease -11.02% -8.95K shares 340K $21.71 72.31K
Q4 2020 share Decrease -54.65% -97.92K shares -1.27M $15.13 81.26K
Q3 2020 call Decrease -100.00% -500 shares -9K $12.73 0
Q3 2020 share Decrease -0.40% -723 shares -570K $12.73 179.19K
Q2 2020 share Decrease -0.02% -34 shares 700K $17.1 179.92K
Q2 2020 call Increase 0.00% 500 shares 9K $17.1 500
Q1 2020 share Decrease -2.24% -4.13K shares -589K $13.21 179.95K
Q4 2019 share Increase 0.00% 184.08K shares 2.96M $16.11 184.08K
Q3 2018 share Decrease -100.00% -74.44K shares -1.42M $23.95 0
Q2 2018 share Increase 0.00% 74.44K shares 1.42M $19.15 74.44K